HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Donald P Kotler

Abstract

It has been demonstrated that patients on highly active antiretroviral therapy are at increased risk for developing metabolic abnormalities that include elevated levels of serum triglycerides and low-density lipoprotein cholesterol and reduced levels of high-density lipoprotein cholesterol. This dyslipidemia is similar to that seen in the metabolic syndrome, raising the concern that highly active antiretroviral therapy also potentially increases the risk for cardiovascular complications. This paper reviews the contribution of both HIV infection and the different components of highly active antiretroviral therapy to dyslipidemia and the role of these abnormalities toward increasing the risk of cardiovascular disease in HIV-infected patients; therapeutic strategies to manage these risks are also considered.

References

Feb 11, 1991·The American Journal of Medicine·C GrunfeldK R Feingold
Aug 3, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel KleinStephen Sidney
Feb 21, 2003·The New England Journal of Medicine·Samuel A BozzetteThomas A Louis
Jun 12, 2003·JAMA : the Journal of the American Medical Association·Sharon A RiddlerLawrence A Kingsley
Jul 19, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith S CurrierSally Hodder
Sep 12, 2003·The New England Journal of Medicine·Esteban MartínezUNKNOWN Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team
Nov 6, 2003·AIDS·Murielle Mary-KrauseUNKNOWN Clinical Epidemiology Group from the French Hospital Database
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Jul 14, 2004·JAMA : the Journal of the American Medical Association·Joel E GallantUNKNOWN 903 Study Group
Nov 16, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel PodzamczerUNKNOWN ABCDE (Abacavir vs. d4T (stavudine) plus efavirenz) Study Team
Apr 27, 2007·The New England Journal of Medicine·UNKNOWN DAD Study GroupJens D Lundgren
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Harold E BaysMichael H Davidson
Apr 1, 2008·The New England Journal of Medicine·John J P KasteleinUNKNOWN ENHANCE Investigators

❮ Previous
Next ❯

Citations

Aug 13, 2011·Journal of General Internal Medicine·Oni J BlackstockDavid A Fiellin
Feb 23, 2010·Enfermedades infecciosas y microbiología clínica·Inés Pérez-CamachoAntonio Rivero
Jul 20, 2011·AIDS Care·Jordan E LakeJudith S Currier
Dec 16, 2011·HIV Therapy·Jordan E Lake, Judith S Currier
Aug 22, 2013·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Asa M MargolisAndrew Stolbach
Feb 7, 2013·The Pediatric Infectious Disease Journal·Agnes LangatGrace C John-Stewart
Jul 8, 2010·Expert Opinion on Drug Metabolism & Toxicology·Divya Samineni, Carl J Fichtenbaum
Oct 12, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Min-Han HsiehYen-Hsu Chen
Oct 18, 2011·The Journal of the Association of Nurses in AIDS Care : JANAC·Hazel Jones-Parker
Aug 13, 2011·The Journal of Infection·George LiamisMoses Elisaf
Mar 10, 2010·Bone·Gianvincenzo ZuccottiStefano Mora
Dec 17, 2009·Advances in Chronic Kidney Disease·Jennifer Jao, Christina M Wyatt
May 12, 2009·The Journal of the Association of Nurses in AIDS Care : JANAC·Roberta Seron SanchesAna Paula Morais Fernandes
Oct 27, 2015·AIDS Research and Human Retroviruses·Alex K BryantDavid J Moore
Nov 1, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·J C K Wells
Sep 14, 2010·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Evanizio Roque de Arruda JuniorVerônica Soares Monteiro
May 29, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Sandra Wagner CardosoBeatriz Grinsztejn
Jun 2, 2016·Current HIV/AIDS Reports·Nicholas T Funderburg, Nehal N Mehta
Sep 24, 2011·Current Problems in Diagnostic Radiology·Ahmed M GharibColleen Hadigan
May 12, 2011·Journal of Tropical Pediatrics·Amandine CournilPhilippe Msellati
Aug 6, 2011·PloS One·Lucille PalazyFranck Courchamp
Apr 28, 2011·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Tereza ConradoFrancisco Bandeira
Feb 20, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jason J SchaferIan R McNicholl
Jun 6, 2009·Current Opinion in Lipidology·Munir Pirmohamed
Mar 2, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Morten BaekkenJan K Damås
Apr 14, 2015·The Open AIDS Journal·Daniel B ChastainKayla R Stover
Sep 2, 2019·Current HIV/AIDS Reports·Corrilynn O Hileman, Grace A McComsey
Jun 5, 2020·Journal of Biomolecular Structure & Dynamics·Kader Sahin
Apr 1, 2010·Journal of Clinical Pathology·David Haarburger, Tahir S Pillay
Oct 30, 2016·Expert Opinion on Investigational Drugs·Michelle B KimLawrence J Wilson
Jun 27, 2019·Current Topics in Medicinal Chemistry·Chandrashekhar Voshavar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.